tiprankstipranks
AstraZeneca PLC (GB:AZN)
LSE:AZN
Holding GB:AZN?
Track your performance easily

AstraZeneca (AZN) Ownership - Who Owns AstraZeneca?

516 Followers

AstraZeneca (AZN) Ownership Overview

0.02%14.72%0.02%8.64%76.60%
0.02% Other Institutional Investors
8.64% ETFs
76.60% Public Companies and
Individual Investors
The ownership structure of AstraZeneca (GB:AZN) stock is a mix of institutional, retail, and individual investors. Approximately 23.38% of the company’s stock is owned by Institutional Investors, 0.02% is owned by Insiders, and 76.60% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 20, 2024
Tony Mok
Non Executive,director
xxxxxxxxxxxxx
$190194
Nov 15, 2024
Michel Demare
Chairman,director
xxxxxxxxxxxxx
£200607
Nov 15, 2024
Pascal Soriot
Chief Executive Officer
xxxxxxxxxxxxx
£2040600
Nov 13, 2024
Philip Arthur.john Broadley
Senior Independent Director
xxxxxxxxxxxxx
£99665

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
63,344,793Institution4.09%8,563,329,186
29,526,422Institution1.90%3,991,558,884
20,847,537Institution1.34%2,818,295,137
17,326,437Institution1.12%2,342,291,712
15,285,063Institution0.99%2,066,326,527
14,672,735Institution0.95%1,983,548,354
12,916,587Institution0.83%1,746,141,730
12,612,963Institution0.81%1,705,096,016
10,319,449Institution0.67%1,395,045,033
9,338,043Institution0.60%1,262,372,681

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
20,847,537Institution1.34%2,818,295,137
17,326,437Institution1.12%2,342,291,712
15,285,063Institution0.99%2,066,326,527
14,672,735Institution0.95%1,983,548,354
12,916,587Institution0.83%1,746,141,730
12,612,963Institution0.81%1,705,096,016
9,338,043Institution0.60%1,262,372,681
8,732,500Institution0.56%1,180,511,745
8,240,528Institution0.53%1,114,004,018
7,733,165Institution0.50%1,045,415,644

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
12,899,679Institution0.83%1,835,541,583
9,727,140Institution0.63%1,223,613,890
5,122,024Institution0.33%644,318,856
3,002,980Institution0.19%427,304,793
2,981,689Institution0.19%424,275,220
270,848Institution0.02%411,824,384
3,675,386Institution0.24%405,836,122
2,954,212Institution0.19%375,063,911
2,871,254Institution0.19%361,185,947
2,002,477Institution0.13%254,232,552

FAQ

Who Owns AstraZeneca PLC (GB:AZN)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 0.02% is held by insiders, and 76.60% is held by retail investors.
    What percentage of AstraZeneca PLC (GB:AZN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.02% of AstraZeneca PLC (GB:AZN) stock is held by institutional investors.
      What percentage of AstraZeneca PLC (GB:AZN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 76.60% of AstraZeneca PLC (GB:AZN) stock is held by retail investors.
        Who owns the most shares of AstraZeneca PLC (GB:AZN)?
        iShares owns the most shares of AstraZeneca PLC (GB:AZN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis